![](/img/cover-not-exists.png)
Nilotinib: a novel Bcr-Abl tyrosine kinase inhibitor for the treatment of leukemias
Jabbour, Elias, El Ahdab, Samih, Cortes, Jorge, Kantarjian, HagopVolume:
17
Language:
english
Journal:
Expert Opinion on Investigational Drugs
DOI:
10.1517/13543784.17.7.1127
Date:
July, 2008
File:
PDF, 316 KB
english, 2008